Age dependence of the rapid antidepressant and synaptic effects of acute NMDA receptor blockade

Elena Nosyreva, Anita E. Autry-Dixon, Ege T. Kavalali, Lisa M. Monteggia

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Ketamine is a N-methyl-D-aspartate receptor (NMDAR) antagonist that produces rapid antidepressant responses in individuals with major depressive disorder.The antidepressant action of ketamine has been linked to blocking NMDAR activation at rest, which inhibits eukaryotic elongation factor 2 kinase leading to desuppression of protein synthesis and synaptic potentiation in the CA1 region of the hippocampus. Here, we investigated ketamine mediated antidepressant response and the resulting synaptic potentiation in juvenile animals. We found that ketamine did not produce an antidepressant response in juvenile animals in the novelty suppressed feeding or the forced swim test. In addition ketamine application failed to trigger synaptic potentiation in hippocampal slices obtained from juvenile animals, unlike its action in slices from adultanimals.The inability of ketamine to trigger an antidepressant response or subsequent synaptic plasticity processes suggests a developmental component to ketamine mediated antidepressant efficacy. We also show that the NMDAR antagonist AP5 triggers synaptic potentiation in mature hippocampus similar to the action of ketamine, demonstrating that global competitive blockade of NMDARs is sufficient to trigger this effect. These findings suggest that global blockade of NMDARs in developmentally mature hippocampal synapses are required for the antidepressant efficacy of ketamine.

Original languageEnglish (US)
Article number94
JournalFrontiers in Molecular Neuroscience
Volume7
Issue numberDEC
DOIs
StatePublished - Dec 1 2014
Externally publishedYes

Fingerprint

Ketamine
N-Methyl-D-Aspartate Receptors
Antidepressive Agents
Elongation Factor 2 Kinase
Hippocampus
Neuronal Plasticity
Major Depressive Disorder
Synapses

Keywords

  • Antidepressant
  • Behavior
  • Development
  • Ketamine
  • Synaptic potentiation

ASJC Scopus subject areas

  • Molecular Biology
  • Cellular and Molecular Neuroscience

Cite this

Age dependence of the rapid antidepressant and synaptic effects of acute NMDA receptor blockade. / Nosyreva, Elena; Autry-Dixon, Anita E.; Kavalali, Ege T.; Monteggia, Lisa M.

In: Frontiers in Molecular Neuroscience, Vol. 7, No. DEC, 94, 01.12.2014.

Research output: Contribution to journalArticle

@article{01e44f3ab75e40b49c593f4e95544a69,
title = "Age dependence of the rapid antidepressant and synaptic effects of acute NMDA receptor blockade",
abstract = "Ketamine is a N-methyl-D-aspartate receptor (NMDAR) antagonist that produces rapid antidepressant responses in individuals with major depressive disorder.The antidepressant action of ketamine has been linked to blocking NMDAR activation at rest, which inhibits eukaryotic elongation factor 2 kinase leading to desuppression of protein synthesis and synaptic potentiation in the CA1 region of the hippocampus. Here, we investigated ketamine mediated antidepressant response and the resulting synaptic potentiation in juvenile animals. We found that ketamine did not produce an antidepressant response in juvenile animals in the novelty suppressed feeding or the forced swim test. In addition ketamine application failed to trigger synaptic potentiation in hippocampal slices obtained from juvenile animals, unlike its action in slices from adultanimals.The inability of ketamine to trigger an antidepressant response or subsequent synaptic plasticity processes suggests a developmental component to ketamine mediated antidepressant efficacy. We also show that the NMDAR antagonist AP5 triggers synaptic potentiation in mature hippocampus similar to the action of ketamine, demonstrating that global competitive blockade of NMDARs is sufficient to trigger this effect. These findings suggest that global blockade of NMDARs in developmentally mature hippocampal synapses are required for the antidepressant efficacy of ketamine.",
keywords = "Antidepressant, Behavior, Development, Ketamine, Synaptic potentiation",
author = "Elena Nosyreva and Autry-Dixon, {Anita E.} and Kavalali, {Ege T.} and Monteggia, {Lisa M.}",
year = "2014",
month = "12",
day = "1",
doi = "10.3389/fnmol.2014.00094",
language = "English (US)",
volume = "7",
journal = "Frontiers in Molecular Neuroscience",
issn = "1662-5099",
publisher = "Frontiers Research Foundation",
number = "DEC",

}

TY - JOUR

T1 - Age dependence of the rapid antidepressant and synaptic effects of acute NMDA receptor blockade

AU - Nosyreva, Elena

AU - Autry-Dixon, Anita E.

AU - Kavalali, Ege T.

AU - Monteggia, Lisa M.

PY - 2014/12/1

Y1 - 2014/12/1

N2 - Ketamine is a N-methyl-D-aspartate receptor (NMDAR) antagonist that produces rapid antidepressant responses in individuals with major depressive disorder.The antidepressant action of ketamine has been linked to blocking NMDAR activation at rest, which inhibits eukaryotic elongation factor 2 kinase leading to desuppression of protein synthesis and synaptic potentiation in the CA1 region of the hippocampus. Here, we investigated ketamine mediated antidepressant response and the resulting synaptic potentiation in juvenile animals. We found that ketamine did not produce an antidepressant response in juvenile animals in the novelty suppressed feeding or the forced swim test. In addition ketamine application failed to trigger synaptic potentiation in hippocampal slices obtained from juvenile animals, unlike its action in slices from adultanimals.The inability of ketamine to trigger an antidepressant response or subsequent synaptic plasticity processes suggests a developmental component to ketamine mediated antidepressant efficacy. We also show that the NMDAR antagonist AP5 triggers synaptic potentiation in mature hippocampus similar to the action of ketamine, demonstrating that global competitive blockade of NMDARs is sufficient to trigger this effect. These findings suggest that global blockade of NMDARs in developmentally mature hippocampal synapses are required for the antidepressant efficacy of ketamine.

AB - Ketamine is a N-methyl-D-aspartate receptor (NMDAR) antagonist that produces rapid antidepressant responses in individuals with major depressive disorder.The antidepressant action of ketamine has been linked to blocking NMDAR activation at rest, which inhibits eukaryotic elongation factor 2 kinase leading to desuppression of protein synthesis and synaptic potentiation in the CA1 region of the hippocampus. Here, we investigated ketamine mediated antidepressant response and the resulting synaptic potentiation in juvenile animals. We found that ketamine did not produce an antidepressant response in juvenile animals in the novelty suppressed feeding or the forced swim test. In addition ketamine application failed to trigger synaptic potentiation in hippocampal slices obtained from juvenile animals, unlike its action in slices from adultanimals.The inability of ketamine to trigger an antidepressant response or subsequent synaptic plasticity processes suggests a developmental component to ketamine mediated antidepressant efficacy. We also show that the NMDAR antagonist AP5 triggers synaptic potentiation in mature hippocampus similar to the action of ketamine, demonstrating that global competitive blockade of NMDARs is sufficient to trigger this effect. These findings suggest that global blockade of NMDARs in developmentally mature hippocampal synapses are required for the antidepressant efficacy of ketamine.

KW - Antidepressant

KW - Behavior

KW - Development

KW - Ketamine

KW - Synaptic potentiation

UR - http://www.scopus.com/inward/record.url?scp=84914709154&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84914709154&partnerID=8YFLogxK

U2 - 10.3389/fnmol.2014.00094

DO - 10.3389/fnmol.2014.00094

M3 - Article

AN - SCOPUS:84914709154

VL - 7

JO - Frontiers in Molecular Neuroscience

JF - Frontiers in Molecular Neuroscience

SN - 1662-5099

IS - DEC

M1 - 94

ER -